Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-12-28Clinical Trial Update: A Study Evaluating Dalotuzumab (MK-0646) in Combination With Erlotinib for Participants With Non-Small Cell Lung Cancer (MK-0646-007) [Phase 2]
Phase 2 clinical trial evaluating dalotuzumab in combination with erlotinib for non-small cell lung cancer has completed with posted results…
-
CLINICAL_TRIALS research · 2016-12-28Clinical Trial Update: EGFR-TKI With/Without Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism [Phase 2]
This Phase 2 trial is evaluating whether adding chemotherapy to an EGFR tyrosine kinase inhibitor improves outcomes in non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2016-12-23Clinical Trial Update: Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing surgery with or without internal radiation therapy in stage I non-small cell lung cancer has completed with results …
-
EMA withdrawal · 2016-12-21EMA Application withdrawn: Pemetrexed ditromethamine Hospira (pemetrexed ditromethamine)
The EMA withdrew the application for pemetrexed ditromethamine Hospira, a pemetrexed conjugate, for mesothelioma and non-small cell lung car…
-
CLINICAL_TRIALS research · 2016-12-20Clinical Trial Update: Complete Endosonographic Intrathoracic Nodal Staging of Lung Cancer Patients in Whom SABR is Considered
Clinical trial update describing complete endosonographic intrathoracic nodal staging for NSCLC patients considered for SABR; current trial …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: A Study of Atezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [FIR] [Phase 2]
Phase 2 trial update of atezolizumab in PD-L1 positive locally advanced or metastatic non-small cell lung cancer completed with results post…
-
CLINICAL_TRIALS research · 2016-12-16Clinical Trial Update: To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer [Phase 2, Phase 3]
This document outlines a Phase II/III trial of Anlotinib in advanced non-small cell lung cancer, focusing on predicting efficacy by measurin…
-
CLINICAL_TRIALS withdrawal · 2016-12-16Clinical Trial Update: Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer [NA]
A clinical trial evaluating diffusion-weighted MRI for individualized radiation therapy planning in non-small cell lung cancer has been with…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 study evaluated a regimen of carboplatin, irinotecan, and radiation therapy followed by docetaxel in patients with newly diagnosed…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 study of ABI-007 administered weekly in chemotherapy-naive patients with advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
This clinical trial update outlines a Phase 2 study evaluating gemcitabine plus oxaliplatin as second-line therapy for stage III or IV non-s…
-
CLINICAL_TRIALS research · 2016-12-15Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage III, Stage IV, or Relapsed Non-Small Cell Lung Cancer Treated With First-Line Chemotherapy [Phase 1]
Phase 1 clinical trial evaluating a vaccine therapy in patients with stage III/IV or relapsed non-small cell lung cancer who received first-…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer [Phase 2]
This Phase 2 trial update reports the completion of a study evaluating gefitinib alone or in combination with carboplatin and paclitaxel in …
-
CLINICAL_TRIALS research · 2016-12-14Clinical Trial Update: Single-port, Two-port Versus Three-port VATS on Non-small Cell Lung Cancer [NA]
This clinical trial compares single-port, two-port, and three-port video-assisted thoracoscopic surgery (VATS) for non-small cell lung cance…
-
CLINICAL_TRIALS research · 2016-12-14Clinical Trial Update: Correlation Between EGFR Mutation Using cfDNAs and Circulating Tumor Cells in Patients With NSCLC
This clinical trial investigates the relationship between EGFR mutations detected in circulating cell-free DNA and circulating tumor cells i…
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 study of temsirolimus plus pemetrexed in recurrent or refractory Non-Small Cell Lung Cancer was terminated, with results posted De…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating carboplatin, Abraxane, and bevacizumab in previously untreated advanced non-small cell lung cancer completed with r…
-
CLINICAL_TRIALS trial_result · 2016-12-09Clinical Trial Update: Early Palliative Care on Quality of Life of Advanced Cancer Patients [Phase 3]
A Phase 3 trial evaluating whether early palliative care improves quality of life in advanced cancers. The study includes non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating pemetrexed disodium plus gemcitabine for locally advanced or metastatic non-small cell lung cancer has completed.…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study of ARQ 197 Plus Erlotinib Versus Placebo Plus Erlotinib [Phase 3]
Phase 3 randomized trial evaluating tivantinib (ARQ 197) plus erlotinib versus placebo plus erlotinib in non-small cell lung cancer; the stu…
-
CLINICAL_TRIALS withdrawal · 2016-12-07Clinical Trial Update: Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05) [Phase 3]
A Phase 3 trial evaluating docetaxel with or without infliximab for cancer-related weight loss in unresectable non-small cell lung cancer; i…
-
CLINICAL_TRIALS withdrawal · 2016-12-07Clinical Trial Update: A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients [Phase 1, Phase 2]
This Phase 1/Phase 2 trial evaluating CDX-1401 in combination with Poly-ICLC and pembrolizumab for previously treated advanced solid tumors …
-
CLINICAL_TRIALS research · 2016-12-06Clinical Trial Update: CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor [Phase 1, Phase 2]
A Phase 1/2 trial evaluating CAR-pNK cell immunotherapy for MUC1-positive relapsed or refractory solid tumors; current status is not provide…
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Dynamic Circulating Tumor Cell (CTC) Changes During the Chemotherapy in NSCLC
A completed clinical trial investigating dynamic changes in circulating tumor cells during chemotherapy for non-small cell lung cancer. The …
-
CLINICAL_TRIALS research · 2016-12-05Clinical Trial Update: Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor [Phase 1, Phase 2]
Phase 1/2 trial evaluating Anti-Mucin1 (MUC1) CAR T cells in patients with MUC1-positive advanced refractory solid tumors across several can…